# PHC Holdings

> PHC Holdings is a VC fund in Tokyo backing Health Care and Medical. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 6
- Last investment: Mar 2023
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/phc-holdings/about/
- Website: https://www.phchd.com/jp
- Facebook: https://www.facebook.com/PHCHoldingsJP/

PHC Holdings is a VC fund in Tokyo focused on Health Care and Medical. Panasonic Healthcare is a global corporation focused on the development of healthcare and research technology. Known throughout the world as a leader in consumer electronics and appliances, Panasonic addresses global needs, such as energy, food, housing, health, and information technology. Here at Panasonic Healthcare, we combine ideas andinnovations from our worldwide network of industrial and consumer products into a complete line of biomedical products.

## Contacts

5 contacts available for PHC Holdings. Shizune tracks 10 team members at PHC Holdings. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/panasonic-healthcare-holdings?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 50% |
| Medical | 2 | 33% |
| Biotechnology | 2 | 33% |
| Medical Device | 2 | 33% |
| Sensor | 1 | 17% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 17% |
| Series C | 1 | 17% |
| Series D | 1 | 17% |
| Post-IPO Debt | 1 | 17% |
| Post-IPO Equity | 1 | 17% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Finland | 1 | 17% |
| Switzerland | 1 | 17% |
| United States | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hidehito Kotani | President & CEO & CTO; Director | 0 | https://shizune.co/investors/profile/hidehito-kotani |
| Hiroaki Kondo | Representative Director & Senior Corporate Executive Officer & COO | 0 | https://shizune.co/investors/profile/hiroaki-kondo |
| Kenji Yamane | Chairman | 0 | https://shizune.co/investors/profile/kenji-yamane |
| Koichiro Sato | COO | 0 | https://shizune.co/investors/profile/koichiro-sato |
| Masatsugu Miyazaki | Vice President & COO | 0 | https://shizune.co/investors/profile/miyazaki-masatsugu |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lunaphore | Lunaphore Technologies S.A. is a Swiss company born with the vision of accelerating cancer research by bringing the field of spatial biology into mainstream laboratories. Lunaphore has developed its innovative spatial biology solutions based on an award-winning technology called FFeX (Fast Fluidic Exchange). Lunaphore has been recognized as one ofthe most innovative companies internationally. | $32.7M | Series D | Mar 23, 2023 |  |
| Lunaphore | Lunaphore Technologies S.A. is a Swiss company born with the vision of accelerating cancer research by bringing the field of spatial biology into mainstream laboratories. Lunaphore has developed its innovative spatial biology solutions based on an award-winning technology called FFeX (Fast Fluidic Exchange). Lunaphore has been recognized as one ofthe most innovative companies internationally. | $12M | Convertible Note | Aug 01, 2021 |  |
| Aiforia | Aiforia Technologies was founded as a spin-off company from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki in 2013 by researchers and pioneers in the field of cloud-based microscopy and pathology and experienced life science entrepreneurs. The Aiforia® Platform brings together deep learning AI and high-performancecloud computing. Aiforia assists with the increased demand for image-based diagnostics by providing efficient and scalable solutions – enabling new discoveries and clinical support with highly accurate and consistent data. Aiforia is technologically driven establishment and keeps the capability of being image agnostic thus extending its solutions to multiple fields. | $15.3M | Series B | Jun 08, 2021 |  |
| Senseonics | Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. | $45M | Post-IPO Equity | Aug 10, 2020 |  |
| Senseonics | Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. | $35M | Post-IPO Debt | Aug 10, 2020 |  |
| Lunaphore | Lunaphore Technologies S.A. is a Swiss company born with the vision of accelerating cancer research by bringing the field of spatial biology into mainstream laboratories. Lunaphore has developed its innovative spatial biology solutions based on an award-winning technology called FFeX (Fast Fluidic Exchange). Lunaphore has been recognized as one ofthe most innovative companies internationally. | $23.6M | Series C | Feb 06, 2020 |  |

6 of 6 investments shown.

## Co-investors
- [OCCIDENT](https://shizune.co/investors/profile/occident-group) — VC Fund, 3 deals together
- [Alpana Ventures](https://shizune.co/investors/profile/alpana-ventures) — VC Fund, 2 deals together
- [redalpine](https://shizune.co/investors/profile/redalpine-venture-partners) — VC Fund, 2 deals together
- [Ernst Gohner Stiftung](https://shizune.co/investors/profile/ernst-gohner-stiftung) — VC Fund, 1 deal together
- [Masters Capital Management](https://shizune.co/investors/profile/masters-capital-management) — VC Fund, 1 deal together
- [Swiss Entrepreneurs Fund](https://shizune.co/investors/profile/swiss-entrepreneurs-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does PHC Holdings invest in?

PHC Holdings invests primarily in Health Care, Medical and Biotechnology startups, most often at Series B and Series C stage. Most of the 6 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact PHC Holdings?

Public channels for PHC Holdings include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at PHC Holdings?

The team at PHC Holdings includes Hidehito Kotani (President & CEO & CTO; Director), Hiroaki Kondo (Representative Director & Senior Corporate Executive Officer & COO) and Kenji Yamane (Chairman), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co